Latest Advances in Lung Cancer Research

Phase III trial shows mobocertinib performs similarly to chemotherapy for EGFR exon 20 insertion lung cancer patients.

New blood test using ctDNA methylation biomarkers shows promise for early lung cancer detection, potentially improving treatment outcomes for patients.

Comprehensive review examining molecular mechanisms of cancer invasion and metastasis, identifying potential therapeutic targets for preventing cancer spread.

Final clinical trial results demonstrate selpercatinib’s safety and efficacy in treating RET fusion-positive non-small cell lung cancer patients.

Increasing lung cancer cases in non-smokers highlight the need for research into causes and improved detection methods

Obesity paradox in lung cancer: Study finds obesity associated with improved survival in NSCLC patients, particularly those with preserved skeletal muscle quality and quantity.

Expanding lung cancer screening to those aged 50-80 with 20 pack-year smoking history could increase eligibility by 87%, reducing disparities and saving lives.

Lung cancer mortality trends show significant disparities by sex, age, and ethnicity, with declining rates overall but persistent gaps in healthcare access and outcomes.

New study reveals higher lung cancer incidence in women under 65 than in men, with rates increasing among younger women despite declining smoking trends.

New study reveals genetic factors protect some lifelong smokers from lung cancer, identifying robust mechanisms that limit mutation accumulation and improve early detection strategies

The Veterans Health Administration promotes lung cancer screening with low-dose CT scans for eligible veterans aged 50-80 with a 20+ pack-year smoking history.

The Lung Cancer Genetics Study aims to understand genetic factors in lung cancer, improving detection, risk reduction, and care through a collaborative research effort.